We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
-11.86%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$36.7B
AUM Growth
-$6.2B
Cap. Flow
-$573M
Cap. Flow %
-1.56%
Top 10 Hldgs %
17.72%
Holding
2,421
New
183
Increased
751
Reduced
1,111
Closed
239

Top Sells

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$322M
2
KO icon
Coca-Cola
KO
+$291M
3
PFE icon
Pfizer
PFE
+$206M
4
PEG icon
Public Service Enterprise Group
PEG
+$205M
5
DUK icon
Duke Energy
DUK
+$169M

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 12.54%
3 Consumer Staples 10.83%
4 Financials 10.24%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
2051
Sarepta Therapeutics
SRPT
$1.64B
$3K ﹤0.01%
26
-9,415
-100% -$1.18M
STGW icon
2052
Stagwell
STGW
$2B
$3K ﹤0.01%
+1,095
New +$3.12K
VYNE icon
2053
VYNE Therapeutics
VYNE
0
WYNN icon
2054
Wynn Resorts
WYNN
$10.3B
$3K ﹤0.01%
30
-1,193
-98% -$129K
QTTB icon
2055
Q32 Bio
QTTB
$435M
$3K ﹤0.01%
7
-1
-13% -$378
CMRX
2056
DELISTED
Chimerix, Inc.
CMRX
$3K ﹤0.01%
1,089
LUMO
2057
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3K ﹤0.01%
224
-169
-43% -$2.98K
MCBC
2058
DELISTED
Macatawa Bank Corp
MCBC
$3K ﹤0.01%
321
-845
-72% -$8.8K
INFI
2059
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$3K ﹤0.01%
2,308
ACGN
2060
DELISTED
Aceragen Inc
ACGN
$3K ﹤0.01%
+66
New +$7.59K
BDR
2061
DELISTED
Blonder Tongue Laboratories Inc
BDR
$3K ﹤0.01%
2,851
FPRX
2062
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3K ﹤0.01%
278
+99
+55% +$1.18K
BFYT
2063
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$3K ﹤0.01%
+107
New +$4.29K
UPL
2064
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$3K ﹤0.01%
3,452
+2,808
+436% +$3.55K
INSY
2065
DELISTED
Insys Therapeutics, Inc.
INSY
$3K ﹤0.01%
777
AKAO
2066
DELISTED
Achaogen Inc
AKAO
$3K ﹤0.01%
+2,500
New +$6.67K
ACLS icon
2067
Axcelis
ACLS
$3.44B
$2K ﹤0.01%
+129
New +$2.29K
AVD icon
2068
American Vanguard Corp
AVD
$68.7M
$2K ﹤0.01%
149
-36
-19% -$593
BCML icon
2069
BayCom
BCML
$335M
$2K ﹤0.01%
+87
New +$2.08K
BH icon
2070
Biglari Holdings Class B
BH
$1.2B
$2K ﹤0.01%
+20
New +$2.95K
CUBI icon
2071
Customers Bancorp
CUBI
$2.66B
$2K ﹤0.01%
117
-13
-10% -$260
CULP icon
2072
Culp Inc
CULP
$45.2M
$2K ﹤0.01%
129
-6
-4% -$130
DHX icon
2073
DHI Group
DHX
$177M
$2K ﹤0.01%
1,604
-422
-21% -$729
FAX
2074
abrdn Asia-Pacific Income Fund
FAX
$592M
$2K ﹤0.01%
+82
New +$1.96K
FCBC icon
2075
First Community Bankshares
FCBC
$899M
$2K ﹤0.01%
67
-27
-29% -$900

Similar funds

Federated Hermes's Q4 2018 Portfolio in Review

As of Q4 2018, Federated Hermes held 2,421 positions worth $36.7B, down 14% from $42.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Federated Hermes's Q4 2018 filing shows 183 new, 751 increased, 1,111 reduced and 239 closed positions. Its largest new stake was Credicorp: 615,567 shares worth $136M. The largest sale was Public Storage, an estimated $322M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Federated Hermes's largest Q4 2018 buy was Credicorp: 615,567 shares worth $136M.
  • Federated Hermes added most to AbbVie in Q4 2018, an estimated $238M increase.
  • Federated Hermes's biggest Q4 2018 reduction was Public Storage, cutting an estimated $322M.
  • Federated Hermes fully exited MINDBODY, Inc. Class A Common Stock in Q4 2018, selling an estimated $25M.
  • Federated Hermes's ten largest holdings make up 18% of its $36.7B portfolio in Q4 2018.
  • Federated Hermes opened 183 new positions and closed 239 in Q4 2018.
  • Federated Hermes's portfolio value fell 14% quarter-over-quarter to $36.7B.

Based on Federated Hermes's 13F filing for Q4 2018, filed 13 Feb 2019.